Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jan;19(1):e2300161.
doi: 10.1002/biot.202300161. Epub 2023 Oct 28.

Heterologous expression of NoxA confers aerotolerance in Clostridium sporogenes

Affiliations

Heterologous expression of NoxA confers aerotolerance in Clostridium sporogenes

Sara Sadr et al. Biotechnol J. 2024 Jan.

Abstract

Clostridium is a genus of gram-positive obligate anaerobic bacteria. Some species of Clostridium, including Clostridium sporogenes, may be of use in bacteria-mediated cancer therapy. Spores of Clostridium are inert in healthy normoxic tissue but germinate when in the hypoxic regions of solid tumors, causing tumor regression. However, such treatments fail to completely eradicate tumors partly because of higher oxygen levels at the tumor's outer rim. In this study, we demonstrate that a degree of aerotolerance can be introduced to C. sporogenes by transfer of the noxA gene from Clostridium aminovalericum. NoxA is a water-forming NADH oxidase enzyme, and so has no detrimental effect on cell viability. In addition to its potential in cancer treatment, the noxA-expressing strain described here could be used to alleviate challenges related to oxygen sensitivity of C. sporogenes in biomanufacturing.

Keywords: C. sporogenes; Clostridia; NADH oxidase; aerotolerance; noxA gene.

PubMed Disclaimer

References

REFERENCES

    1. Kubiak, A. M., Poehlein, A., Budd, P., Kuehne, S. A., Winzer, K., Theys, J., Lambin, P., Daniel, R., & Minton, N. P. (2015). Complete genome sequence of the nonpathogenic soil-dwelling bacterium Clostridium sporogenes strain NCIMB 10696. Genome Announcements, 3, 4-5.
    1. Fox, M. E., Lemmon, M. J., Mauchline, M. L., Davis, T. O., Giaccia, A. J., Minton, N. P., & Brown, J. M. (1996). Anaerobic bacteria as a delivery system for cancer gene therapy: In vitro activation of 5-fluorocytosine by genetically engineered clostridia. Gene Therapy, 3, 173-178.
    1. Kubiak, A. M., & Minton, N. P. (2015). The potential of clostridial spores as therapeutic delivery vehicles in tumour therapy. Research in Microbiology, 166, 244-254.
    1. Mowday, A. M., Guise, C. P., Ackerley, D. F., Minton, N. P., Lambin, P., Dubois, L. J., Theys, J., Smaill, J. B., & Patterson, A. V. (2016). Advancing clostridia to clinical trial: past lessons and recent progress. Cancers (Basel), 8, 63. https://doi.org/10.3390/cancers8070063
    1. Lemmon, M. J., Van Zijl, P., Fox, M. E., Mauchline, M. L., Giaccia, A. J., Minton, N. P., & Brown, J. M. (1997). Anaerobic bacteria as a gene delivery system that is controlled by the tumor microenvironment. Gene Therapy, 4, 791-796.

Supplementary concepts

Grants and funding

LinkOut - more resources